Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Pollack

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Ophthalmology|March 19, 2019
Small gauge vitrectomy: operative techniquesJohn S Pollack, Naryan Sabherwal
Retina (Philadelphia, Pa.)|January 28, 2012
Comparison of topical anesthetics for intravitreal injections : a randomized clinical trialMichael J Davis, John S Pollack, Susan Shott
The British Journal of Ophthalmology|October 15, 2020
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyesThomas Ciulla, John S Pollack, David F Williams
The British Journal of Ophthalmology|April 9, 2020
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyesThomas A Ciulla, John S Pollack, David F Williams
Ophthalmology. Retina|July 21, 2019
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 EyesThomas A Ciulla, Rehan M Hussain, John S Pollack, et al.
Ophthalmology|February 5, 2002
Clinical characteristics of central serous chorioretinopathy in womenStephen L Perkins, Judy E Kim, John S Pollack, et al.
Current Eye Research|December 14, 2004
Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitisJohn S Pollack, Douglas J Beecher, Jose S Pulido, et al.
Ophthalmology. Retina|April 5, 2022
Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 EyesThomas A Ciulla, Rehan M Hussain, Donna Taraborelli, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2004
Is coxsackievirus the cause of unilateral acute idiopathic maculopathy?Adam P Beck, Lee M Jampol, David A Glaser, et al.
Retina (Philadelphia, Pa.)|May 9, 2008
ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edemaJudy E Kim, John S Pollack, David G Miller, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Ophthalmology|March 19, 2019
Small gauge vitrectomy: operative techniquesJohn S Pollack, Naryan Sabherwal
Retina (Philadelphia, Pa.)|January 28, 2012
Comparison of topical anesthetics for intravitreal injections : a randomized clinical trialMichael J Davis, John S Pollack, Susan Shott
The British Journal of Ophthalmology|October 15, 2020
Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyesThomas Ciulla, John S Pollack, David F Williams
The British Journal of Ophthalmology|April 9, 2020
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyesThomas A Ciulla, John S Pollack, David F Williams
Ophthalmology. Retina|July 21, 2019
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 EyesThomas A Ciulla, Rehan M Hussain, John S Pollack, et al.
Ophthalmology|February 5, 2002
Clinical characteristics of central serous chorioretinopathy in womenStephen L Perkins, Judy E Kim, John S Pollack, et al.
Current Eye Research|December 14, 2004
Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitisJohn S Pollack, Douglas J Beecher, Jose S Pulido, et al.
Ophthalmology. Retina|April 5, 2022
Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 EyesThomas A Ciulla, Rehan M Hussain, Donna Taraborelli, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2004
Is coxsackievirus the cause of unilateral acute idiopathic maculopathy?Adam P Beck, Lee M Jampol, David A Glaser, et al.
Retina (Philadelphia, Pa.)|May 9, 2008
ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edemaJudy E Kim, John S Pollack, David G Miller, et al.
Pageof 2